Exploring health inequities in inflammatory bowel disease

Inflammatory bowel disease (IBD), encompassing Crohn's disease, ulcerative colitis, and IBD unclassified, is a chronic condition with a rising global burden and evolving epidemiological patterns. Emerging evidence highlights significant disparities in IBD prevalence and outcomes, driven by socioeconomic status, race, ethnicity and geography. Marginalised and minority populations are disproportionally affected by delayed diagnosis, reduced access to advanced therapies, and higher rates of complications, highlighting systemic inequities in healthcare systems. In addition to physical morbidity, IBD is associated with significant psychological distress and disability, often exacerbated by social determinants of health. Addressing these challenges requires a coordinated focus on culturally competent care, targeted policy initiative and inclusive research to bridge gaps in access and outcomes. Empowering IBD nurse specialists to lead multidisciplinary, patient-centred interventions is highlighted as a key strategy for advancing equity and improving outcomes. Achieving this will depend on sustained efforts to recognise and address the complex interplay of demographics, social and systemic factors shaping disease experience and health trajectories across diverse populations.